Skip to main content
Fig. 10 | Cancer Nanotechnology

Fig. 10

From: Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer

Fig. 10

TGFβ-1 siRNA LNP combined with CTX-HSA-NPs downregulated TGFβ-1 protein expression in tumor tissues. A TGFβ-1 expression level in nude mice bearing paclitaxel-resistant non-small cell lung cancer after treatment. B The average optical density values of tumor immunohistochemical sections from nude mice bearing paclitaxel-resistant non-small cell lung cancer after treatment. (*P < 0.05, **P < 0.01) (scale bar = 50 μm) (n = 4)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us